A clinical trial to test the safety of a drug
Phase 1
Completed
- Registration Number
- CTRI/2017/11/010540
- Lead Sponsor
- SK Biolabs
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Adult healthy human volunteers
Exclusion Criteria
Patients suffering from any disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Any toxic side effects after oral administration of SKBRADHA such as fever, nausea, vomiting, cough, choking, fainting, diarrhea, palpitations, stomach upset, skin rashes, depression, dizziness, heartburn, acidity, weakness, pain, constipation etc.Timepoint: 4 Hours
- Secondary Outcome Measures
Name Time Method Any toxic side effects after oral administration of SKBRADHA such as fever, nausea, vomiting, cough, choking, fainting, diarrhea, palpitations, stomach upset, skin rashes, depression, dizziness, heartburn, acidity, weakness, pain, constipation etc.Timepoint: 8 days